Showing results (1471-1480 of 1,588) with videos related to
Sort By:
Pageof 159
Dermatology and Therapy|January 13, 2022
Deucravacitinib in Moderate to Severe Psoriasis: Clinical and Quality-of-Life Outcomes in a Phase 2 TrialDiamant Thaçi, Bruce Strober, Kenneth B Gordon, et al.The British Journal of Dermatology|August 28, 2025
SPECTREM Phase 3b Clinical Trial Results Through Week 16: Guselkumab Efficacy and Safety for the Treatment of Low Body Surface Area, Moderate Psoriasis With High-Impact Site InvolvementLinda Stein Gold, Alice B Gottlieb, April W Armstrong, et al.American Journal of Respiratory and Critical Care Medicine|February 2, 2013
Controlled human infection and rechallenge with Streptococcus pneumoniae reveals the protective efficacy of carriage in healthy adultsDaniela M Ferreira, Daniel R Neill, Mathieu Bangert, et al.The Journal of Infectious Diseases|January 29, 2019
Pneumococcal Colonization in Healthy Adult Research Participants in the Conjugate Vaccine Era, United Kingdom, 2010-2017Hugh Adler, Elissavet Nikolaou, Katherine Gould, et al.BMJ Open|January 10, 2024
Serotype 3 Experimental Human Pneumococcal Challenge (EHPC) study protocol: dose ranging and reproducibility in a healthy volunteer population (challenge 3)Phoebe Hazenberg, Ryan E Robinson, Madlen Farrar, et al.Proceedings of the National Academy of Sciences of the United States of America|February 24, 2006
Progressive vascular smooth muscle cell defects in a mouse model of Hutchinson-Gilford progeria syndromeRenee Varga, Maria Eriksson, Michael R Erdos, et al.Journal of Toxicology and Environmental Health. Part B, Critical Reviews|May 7, 1999
Regulating and assessing risks of cholinesterase-inhibiting pesticides: divergent approaches and interpretationsL L Carlock, W L Chen, E B Gordon, et al.Plos One|January 23, 2026
Clinical proof of concept for small molecule mediated inhibition of IL-17 in psoriasisRichard B Warren, Hamish J A Hunter, Kim A Papp, et al.Wellcome Open Research|June 21, 2023
Practical considerations for a TB controlled human infection model (TB-CHIM); the case for TB-CHIM in Africa, a systematic review of the literature and report of 2 workshop discussions in UK and MalawiStephen B Gordon, Simon Sichone, Anthony E Chirwa, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 24, 2022
High Intrapulmonary Rifampicin and Isoniazid Concentrations Are Associated With Rapid Sputum Bacillary Clearance in Patients With Pulmonary TuberculosisAndrew D McCallum, Henry E Pertinez, Aaron P Chirambo, et al.Pageof 159